No Data
No Data
Qualigen Therapeutics Announces Management Changes
Qualigen Therapeutics Appoints Kevin Richardson as Interim CEO and CFO
Express News | Qualigen Therapeutics Inc - Appointed Kevin Richardson as Interim CEO and CFO as Well as a Member of Board
Express News | Qualigen Therapeutics Inc - Christopher Lotz, Chief Financial Office Also Tendered His Resignation From Company
Qualigen Therapeutics: Campbell Becher Named as Pres of the Co, Effective Immediately. >QLGN
Qualigen Therapeutics: Both Resignations Attributed to Disagreements With Co Regarding Future Direction and Strategic Initiatives >QLGN
No Data
No Data